European Journal of Internal Medicine
Volume 19, Issue 8 , Pages 575-578 , December 2008

Systemic polyarteritis nodosa following hepatitis B vaccination

  • Jozélio Freire de Carvalho

      Affiliations

    • Rheumatology Division, São Paulo University School of Medicine, São Paulo, Brazil
    • Department of Internal Medicine B, Center for Autoimmune Diseases, affiliated with Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Israel
    • JF Carvalho is a recipient of grant no. BEX 2367/06-8 awarded by CAPES.
  • ,
  • Rosa Maria Rodrigues Pereira

      Affiliations

    • Rheumatology Division, São Paulo University School of Medicine, São Paulo, Brazil
  • ,
  • Yehuda Shoenfeld

      Affiliations

    • Department of Internal Medicine B, Center for Autoimmune Diseases, affiliated with Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Israel
    • Corresponding Author InformationCorresponding author. Department of Medicine B and Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Tel-Hashomer, 52621, Israel. Tel.: +972 3 5302652; fax: +972 3 5352855.
    • Recipient of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University.

Received 22 February 2007 ,Revised 22 June 2007 ,Accepted 28 June 2007.

References 

  1. Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun. 2001;16:309–318
  2. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore). 1995;74:238–253
  3. Bourgeais AM, Dore MX, Croue A, Leclech C, Verret JL. [Cutaneous polyarteritis nodosa following hepatitis B vaccination]. Ann Dermatol Venereol. 2003;130:205–207
  4. Saadoun D, Cacoub P, Mahoux D, Sbai A, Piette JC. Postvaccine vasculitis: a report of three cases]. Rev Med Interne. 2001;22:172–176
  5. De Keyser F, Naeyaert JM, Hindryckx P, Elewaut D, Verplancke P, Peene I, et al. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol. 2000;18:81–85
  6. Bouroz-Joly J, Hachulla E, Vermersch P, Pruvo JP, Hatron PY, Devulder B. [Between the infection and the vaccine, one must choose]. Rev Med Interne. 1998;19(Suppl 2):286s–289s
  7. Kerleau JM, Levesque H, Lair G, Lecomte F, Carrara O, Courtois H. [Is hepatitis B vaccination a new cause of necrotizing vasculitis?]. Rev Med Interne. 1997;18:491–492
  8. Le Goff P, Fauquert P, Youinou P, Hoang S. [Periarteritis nodosa following vaccination against hepatitis B]. Presse Med. 1988;17:1763
  9. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)–United States, 1991-2001. MMWR Surveill Summ. 2003;52:1–24
  10. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40:1–25
  11. Aharon-Maor A, Shoenfeld Y. The good, the bad and the ugly of vaccination. Isr Med Assoc J. 2000;2:225–227
  12. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunol Today. 1989;10:123–126
  13. Tishler M, Shoenfeld Y. Vaccination may be associated with autoimmune diseases. Isr Med Assoc J. 2004;6:430–432
  14. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985;230:1043–1045
  15. Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol. 2000;18:181–184
  16. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. J Autoimmun. 2000;14:1–10
  17. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13:470–511
  18. Brickman CM, Shoenfeld Y. The mosaic of autoimmunity. Scand J Clin Lab Invest Suppl. 2001;235:3–15
  19. Tudela P, Marti S, Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron. 1992;62:236
  20. Finielz P, Lam-Kam-Sang LF, Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant. 1998;13:2420–2421
  21. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron. 1996;74:4.41
  22. Mamoux V, Dumont C. [Lupus erythematosus disseminatus and vaccination against hepatitis B virus]. Arch Pediatr. 1994;1:307–308
  23. Grezard P, Chefai M, Philippot V, Perrot H, Faisant M. [Cutaneous lupus erythematosus and buccal aphthosis after hepatitis B vaccination in a 6-year-old child]. Ann Dermatol Venereol. 1996;123:657–659
  24. O'Neill SG, Isenberg DA. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus. 2006;15:778–783
  25. Le Hello C, Cohen P, Bousser MG, Letellier P, Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol. 1999;26:191–194
  26. Carmeli Y, De-Medina T. Serious hepatitis B vaccine adverse reactions, are they immune-mediated?. Vaccine. 1993;11:1358–1359
  27. Begier EM, Langford CA, Sneller MC, Wise RP, Ball R. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccineprovoked vasculitis. J Rheumatol. 2004;31:2181–2188
  28. Mader R, Narendran A, Lewtas J, Bykerk V, Goodman RC, Dickson JR, et al. Systemic vasculitis following influenza vaccination–report of 3 cases and literature review. J Rheumatol. 1993;20:1429–1431
  29. Reveille JD, Goodman RE, Barger BO, Acton RT. Familial polyarteritis nodosa: a serologic and immunogenetic analysis. J Rheumatol. 1989;16:181–185
  30. Carmeli Y, Oren R. Hepatitis B vaccine side-effect. Lancet. 1993;341:250–251
  31. Bentsi-Enchill A. Adverse events following the administration of hepatitis B vaccines. Can Commun Dis Rep. 1992;18:49–53
  32. Aron-Maor A, Shoenfeld Y. BCG immunisation and the 'Trojan horse' phenomenon of vaccination. Clin Rheumatol. 2003;22:6–7
  33. Calista D, Morri M. Lichen planus induced by hepatitis B vaccination: a new case and review of the literature. Int J Dermatol. 2004;43:562–564
  34. Al-Khenaizan S. Lichen planus occurring after hepatitis B vaccination: a new case. J Am Acad Dermatol. 2001;45:614–615
  35. Erbagci Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol. 2002;29:781–785
  36. Loche F, Schwarze HP, Thedenat B, Carriere M, Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol. 2000;25:167–168
  37. Chave T, Neal C, Camp R. Henoch-Schonlein purpura following hepatitis B vaccination. J Derm Treat. 2003;14:179–181
  38. Andiran N, Senturk GB, Bukulmez G. Combined vaccination by measles and hepatitis B vaccines: a new cause of Gianotti-Crosti syndrome. Dermatology. 2002;204:75–76
  39. Aron-Maor A, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus. 2001;10:237–240
  40. Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford). 1999;38:978–983
  41. Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol. 1998;25:1687–1693
  42. Nuevo H, Nascimento-Carvalho CM, Athayde-Oliveira CP, Lyra I, Moreira LM. Thrombocytopenic purpura after hepatitis B vaccine: case report and review of the literature. Pediatr Infect Dis J. 2004;23:183–184
  43. Meyboom RH, Fucik H, Edwards IR. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet. 1995;345: 1638
  44. Viallard JF, Boiron JM, Parrens M, Moreau JF, Ranchin V, Reiffers J, et al. Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol. 2000;110:230–233
  45. Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun. 2001;16:309–318
  46. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med. 2001;344:319–326
  47. Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001;344:327–332
  48. Karaali-Savrun F, Altintas A, Saip S, Siva A. Hepatitis B vaccine related-myelitis?. Eur J Neurol. 2001;8:711–715
  49. Creange A, Temam G, Lefaucheur JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity. 1999;30:143–146
  50. Khamaisi M, Shoenfeld Y, Orbach H. Guillain-Barre syndrome following hepatitis B vaccination. Clin Exp Rheumatol. 2004;22:767–770
  51. Pennesi M, Torre G, Del Santo M, Sonzogni A. Glomerulonephritis after recombinant hepatitis B vaccine. Pediatr Infect Dis J. 2002;21:172–173
  52. Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ. 1990;301:345
  53. Louzir B, Othmani S, Battikh R, Ben Abdelhafidh N, Bahri M, Taalouche L, et al. [Myasthenia after hepatitis B vaccination]. Therapie. 2003;58:378–379
  54. Fried M, Conen D, Conzelmann M, Steinemann E. Uveitis after hepatitis B vaccination. Lancet. 1987;2:631–632
  55. Hassan W, Oldham R. Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ. 1994;309:94
  56. Rodriguez-Lopez JN, Banon-Arnao M, Martinez-Ortiz F, Tudela J, Acosta M, Varon R, et al. Catalytic oxidation of 2,4,5-trihydroxyphenylalanine by tyrosinase: identification and evolution of intermediates. Biochim Biophys Acta. 1992;1160:221–228
  57. Lilic D, Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet. 1994;344:1292–1293

PII: S0953-6205(08)00077-0

doi: 10.1016/j.ejim.2007.06.035

European Journal of Internal Medicine
Volume 19, Issue 8 , Pages 575-578 , December 2008